Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.

All ideas
are listed as non-confidential technical summaries.

Ideas were generated by academic institutions, entrepreneurs, and corporations.

Ideas from our research institution partners can be reviewed by following the web links to their database.

Highlighted ideas from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available..

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Rocky Mountain Spotted Fever Canine Vaccine

Researchers have created an inactivated canine vaccine candidate to prevent Rocky Mountain Spotted Fever (RMSF) infection.

RMSF is considered a biosecurity level 3 pathogen because it can infect humans. Kansas State University has the unique facilities and expertise to handle such a pathogen.

Two vaccine candidates were created and tested in host animal studies:
  • whole cell inactivated vaccine
  • recombinant vaccine having two immunogenic proteins.
Dogs receiving the whole cell inactivated vaccine abated clinical signs completely and the pathogen from circulation. Dogs in the recombinant vaccine group did not show any obvious differences in clinical signs compared to non-vaccinated control group. These early results indicate the whole cell inactivated vaccine candidate could hold more promise for vaccine development and should be studied further.

  • RMSF vaccine for dogs

Additional Details


Kansas State University

Intellectual Property Protection

Pending Patent

Interested? Request More Information